Veterinary Medicines

Combotec 402 mg/361.8 mg Spot-on Solution for Extra Large Dogs

Not authorised
  • Methoprene
  • Fipronil
Download as PDF

Product identification

Medicine name:
Combotec 402 mg/361.8 mg Spot-on Solution for Extra Large Dogs
Combotec, 402/361,8mg, Roztok pro nakapání na kůži - spot-on
Active substance:
  • Methoprene
  • Fipronil
Target species:
  • Dog
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • Methoprene
    361.80
    milligram(s)
    /
    1.00
    millilitre(s)
  • Fipronil
    402.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Spot-on solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AX65
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Czechia
Package description:
  • A blue pipette is composed of a heat-formed shell and a film. The blue pipette is enclosed in an aluminum blister. 5 pipettes are packed in a cardboard box.
  • A blue pipette is composed of a heat-formed shell and a film. The blue pipette is enclosed in an aluminum blister. 3 pipettes are packed in a cardboard box.
  • A blue pipette is composed of a heat-formed shell and a film. The blue pipette is enclosed in an aluminum blister. 1 pipette are packed in a cardboard box.
  • A blue pipette is composed of a heat-formed shell and a film. The blue pipette is enclosed in an aluminum blister. 6 pipettes are packed in a cardboard box.
  • A blue pipette is composed of a heat-formed shell and a film. The blue pipette is enclosed in an aluminum blister. 4 pipettes are packed in a cardboard box.
  • A blue pipette is composed of a heat-formed shell and a film. The blue pipette is enclosed in an aluminum blister. 2 pipettes are packed in a cardboard box.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Beaphar B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Beaphar B.V.
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 96/042/20-C
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0251/005